Life SciencesLiability
Get a quote

TL;DR

Miami has become a fast-growing technology and digital health hub, boosted by significant recent tech migration and its position as a gateway between US healthcare and Latin American markets. For telehealth, remote-care, and health-technology companies whose product is software, cyber and technology errors-and-omissions coverage become the primary liability vehicles, layered with HIPAA business-associate exposure, SaMD device structure where applicable, and cross-border data-handling considerations for Latin America-facing companies. Traditional products liability alone is structurally inadequate.

Miami digital health

Digital Health Insurance in Miami

Miami has emerged as a fast-growing technology and digital health center, boosted by significant recent migration of technology companies and talent into South Florida. The metro serves as a gateway between the US healthcare system and Latin American markets, and it produces a steady stream of telehealth, remote-care, and health-technology companies. Florida's large and comparatively older population makes the state a major healthcare and telehealth market in its own right, giving Miami digital health companies both a substantial domestic patient base and a natural bridge to patients and providers across the Americas.

For a digital health company, the product is software, and the exposures follow the code and the data rather than any physical article. A liability program built only around traditional products coverage leaves the core operating risk uninsured, because the loss events are data breaches, algorithm errors, service failures, and regulatory action tied to protected health information. That reality is sharpened in Miami, where many companies handle data flowing across borders into Latin America, adding complexity that the insurance program must be designed to absorb. The coverage architecture below reflects how A-rated specialty markets structure programs for Miami digital health companies.

Get a quoteRun the Free Analyzer

Last updated 2026-07-14

Cluster shape

The Miami digital health cluster

Miami's digital health cluster has grown quickly alongside the broader South Florida technology scene, drawing companies and talent that relocated to the region in recent years. It spans telehealth and virtual-care platforms, remote patient monitoring and remote-care services, and health-technology companies building software for providers, patients, and payers. Florida's large and older population underpins strong demand for these services, making the state a major healthcare and telehealth market and giving local companies a deep domestic base to build on.

A defining feature of the Miami cluster is its role as a gateway between US healthcare and Latin American markets. Many companies here serve, or route data through, patients and providers across the region, which layers cross-border data movement on top of the usual digital health risk profile. From an underwriting standpoint, that means a Miami digital health company is simultaneously a technology vendor, a healthcare-adjacent entity handling protected health information, and, frequently, an operator moving sensitive data across national boundaries.

What ties the cluster together is that software is the product and health data is the raw material. A telehealth platform, a remote-monitoring service, and a health-technology vendor may look different commercially, but each carries the same core exposures: sensitive protected health information, dependence on cloud and third-party infrastructure, and potential clinical consequences when the software misbehaves. That common thread drives the coverage design, from limit selection to the specific policy forms specialty markets will offer.

Coverage architecture

How digital health coverage is structured

For digital health companies, cyber and technology errors-and-omissions (Tech E&O) become the primary product-liability vehicles because the software is the product. Cyber responds to data breaches, ransomware, and privacy events across protected health information, while Tech E&O responds to financial harm caused by errors, failures, or underperformance of the technology itself. These two products, often written together on a combined form, carry the exposure that a traditional products-liability policy is not designed to reach, and traditional products liability alone is structurally inadequate for this class.

HIPAA business-associate scope is a structural pillar of the program. Digital health companies typically create, receive, maintain, or transmit protected health information on behalf of providers and health plans, which makes them business associates under HIPAA and extends direct compliance and breach-notification duties to the company. For Miami companies operating across borders into Latin America, cross-border data-handling adds a further layer of complexity that the cyber program should be built to address, because sensitive health data moving between jurisdictions widens both the breach surface and the regulatory exposure. Where a product qualifies as software as a medical device (SaMD), the program takes on SaMD-specific structure, because the software is then a regulated device carrying bodily-injury and recall-style exposure alongside the economic loss, and algorithm and AI decision-support liability adds another pathway when a model informs a clinical decision.

Underwriters in this class expect a demonstrable security posture, most commonly evidenced by SOC 2 or a comparable attestation, and they price and structure the program around it. A well-built stack from A-rated specialty markets coordinates cyber, Tech E&O, SaMD-aware terms where relevant, and management liability so that a single incident does not fall into a gap between forms, and it treats traditional products liability as a supporting rather than a primary line. Market-typical limits for this class commonly range from roughly $1M-$10M for earlier-stage companies up to $10M-$50M or more for scaled platforms, structured through primary and excess layers.

Regulatory + market context

Regulatory and compliance context

Digital health companies operate under overlapping federal and state regimes, and underwriters read that compliance posture directly into their pricing and terms. HIPAA governs the handling of protected health information across every business-associate relationship, and SaMD products fall within medical-device regulation based on their intended clinical use. For Miami companies, the additional wrinkle is data that moves across borders into Latin American markets, which can bring foreign data-protection obligations into scope and expand the compliance surface beyond a purely domestic footprint.

Underwriters in this class expect a demonstrable security posture as a condition of coverage, commonly evidenced by SOC 2 or a comparable security framework, documented data-governance and encryption practices, and clear controls around any AI or machine-learning components and any cross-border data flows. Companies that can show mature security and privacy programs generally access broader terms and more competitive pricing from specialty carriers, while gaps in these areas translate into higher retentions, sublimited coverage, or declinations.

Frequently asked

Common questions from Miami digital health operators

Why are cyber and Tech E&O the primary coverages for a digital health company?

Because the software is the product. In digital health, losses arise from data breaches, software errors, and service failures rather than a defective physical good, so cyber and technology errors-and-omissions become the vehicles that actually respond. Cyber addresses privacy events and breaches across protected health information, while Tech E&O addresses financial harm from software errors and unmet performance obligations. Traditional products liability alone is structurally inadequate for this class, so cyber and Tech E&O, usually written together, carry the core operating risk.

What does HIPAA business-associate scope mean, and how does cross-border data into Latin America affect it?

When a digital health company creates, receives, maintains, or transmits protected health information on behalf of a provider, health plan, or other covered entity, it acts as a business associate under HIPAA and takes on direct compliance and breach-notification obligations. That scope attaches to essentially every provider and payer relationship in the sector. For Miami companies operating as a gateway into Latin American markets, health data that moves across borders adds complexity, because it can widen the breach surface and bring foreign data-protection requirements into play, so the cyber program should be structured to address cross-border data handling rather than assume a purely domestic footprint.

When is a product considered software as a medical device (SaMD)?

Software is generally treated as software as a medical device when it is intended for a medical purpose such as diagnosis, treatment, or clinical decision-making, on its own rather than as a component of a hardware device, which brings it within medical-device regulation. Once a product is SaMD, the program needs SaMD-specific structure that addresses bodily-injury and recall-style exposures alongside the cyber and Tech E&O core, rather than relying on technology coverage alone. The distinction often turns on intended use and marketing claims, so it should be reviewed carefully with the underwriting team.

What do underwriters expect from a digital health company's security posture?

Specialty underwriters treat security posture as central to the risk and generally expect SOC 2 or a comparable security framework, documented encryption and data-governance practices, and defined controls around any AI or machine-learning components and any cross-border data flows. Companies that can evidence a mature security and privacy program typically access broader terms and more competitive pricing from A-rated specialty markets, while weaker controls lead to higher retentions, sublimits, or declinations.

Telehealth & digital health practice →Digital health startup insurance →Miami biotech insurance →Florida state guide →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Miami digital health operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.